Synthesis and Crystal Structure Of

Total Page:16

File Type:pdf, Size:1020Kb

Synthesis and Crystal Structure Of ChinaXiv合作期刊 卷 期 结 构 化 学(JIEGOU HUAXUE) Vol., No. Chinese J. Struct. Chem. Structural Modification for Antitumor Nitrogenous Steroid XIE Tian-Peng(谢田鹏);YANG Kang(杨康);ZHANG Li-Zhi(张立志);CHEN De-Sheng(陈 德胜);ZOU Kun(邹坤);HUANG Nian-Yu (黄年玉) Hubei Key Laboratory of Natural Products Research and Development, College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang 443002, China ABSTRACT Natural steroids have been showing notable cytotoxic activities, which are quite interesting lead compounds for the development of anticancer drug including estramustine and prednimustine. Considering that these semi-synthetic molecules are nitrogen mustard functionalized steroidal derivatives, the present review is focused on the methodologies of introducing nitrogen atom or nitrogen-containing heterocycles on A~D rings or side chains of steroids, and analysis of the structure-activity relationship (SAR) for these man-made cytotoxic steroids. Keywords: steroids; structural modification; N-hetercycles;antitumor;structure-activity relationship; DOI: 10.14102/j.cnki.0254-5861.2011-1688 1 INTRODUCTION Cancer is one of the leading causes of morbidity and mortality worldwide according to the WHO, and chinaXiv:201711.00153v1 the incidence of most cancers including gastric cancer, 1iver cancer and esophageal cancer in our country has kept gradually increasing over the past 20 years from 1989 to 2008[1]. Despite the availability of a large number of chemotherapeutic drugs, the medical need remains still largely unmet because of drawbacks of the antineoplastic agents, such as drug resistance, the lack of selectivity and cancer metastasis[2]. Natural products are an important original source of many widely used anti-cancer drugs[3]. As one of the widespread class of natural organic compounds occurring in plants, animals and fungi, steroid family has exhibited potent antitumor effects through direct suppression of tumor growth, including reduced cell cycle progression and apoptosis, or inhibiting tumor metastasis[4, 5], and numerous steroidal derivatives have been discovered with potent antineoplastic activity and high tissue selectivity[6]. Cytotoxic steroids like estramustine phosphate, a hybrid structure of estradiol and nitrogen mustard combined through a carbamate ChinaXiv合作期刊 linkage with alkylating capability and estrogen-induced specificity, is marketed as a chemotherapy agent for the treatment of prostate cancer[7, 8], which could also be used as a single chemotherapeutic agent or along with other agents such as 5α-reductase inhibitors[9]. Due to the pivotal role of antineoplastic nitrogenous steroids, the present review will discuss the recent cases for the structural modification on the cyclic backbone (Fig. 1) and corresponding SAR for these steroidal derivatives as anticancer agents. Fig. 1. Cyclic backbone of steroids 2 MODIFICATION OF A~D RINGS OF STEROID SKELETON 2. 1 Modification on the A-ring Poirier’s group reported the preparation of five libraries of 2β-piperazino-5α-androstane-3α,17β-diol derivatives by parallel solid-phase synthesis in 2011[10], and biological evaluation against HL-60 leukemia cells found these aminosteroids revealed interesting SAR. For example, the amide coupling functionality showed stronger cytotoxic activity compared to the corresponding sulfonamides or benzylamines, and six of the most active amide derivatives (Fig. 2, 1 ~ 6) were obtained with low half-maximal inhibitory concentration (IC50) values of 1.7~3.1 μM and high selectivity indices of 5~55. In 2012, amino-pregnane derivatives (7~9) were further prepared by using a sequence of liquid and solid-phase reactions to extend the previous SAR data on anti-leukemic activities[11], and derivative 9 substituted by the 3-acetylbenzoyl group chinaXiv:201711.00153v1 exhibits strong anti-proliferation effect against HL-60 leukemia cells (IC50: 1.9 μM) and low toxicity on normal peripheral blood lymphocytes (IC50: 31 μM). Then, a 5α-androstane-3α,17β-diol derivative with a quinoline nucleus at the end of the piperazine-proline side-chain at position 2β and an ethinyl at position 17α [12, 13] (10) showed the most potent cytotoxic activity against five cancer cell lines studied (IC50: 0.1~1.1 μM for HL-60, MCF-7, T-47D, LNCaP and WEHI-3, respectively), and selectivity experiment towards liver enzymes CYP3A4 and CYP2D6 indicated the aminosteroid possessed a very low risk of drug-drug interactions. In order to increase the in vivo drug potency, an optimized 3-dimethylcarbamate aminosteroid derivative (11) was finally synthesized in 2016 according to the pro-drug strategy targeting on the 3α-hydroxyl group[14], and the lead compound are more selective for cancer cells over normal cells and much more stable in liver microsomes. - 2 - ChinaXiv合作期刊 2016 Vol. 结 构 化 学(JIEGOU HUAXUE)Chinese J. Struct. Chem. Fig. 2. Chemical structures of compounds 1~11 To develop more effective steroidal drugs, we synthesized a library of (25R)-2-[(1H-1,2,3-triazol-4-yl)methoxy]-spirostan-1,4,6-triene-3-ones from diosgenin for anti-tumor screening, and three steroidal triazoles (Fig. 3, 12~14) possessed potent anti-proliferative effects against [15] Caski cells with IC50 of 9.4~11.8 μM . The structure/cytotoxicity investigations implied that the benzyl, 2-oxopropyl or 3-hydroxyphenylethyl substituted steroidal triazoles exhibited excellent anti-tumor activities. Fig. 3. Synthesis of compounds 12~14 chinaXiv:201711.00153v1 Krstić[16] reported the synthesis and anticancer activity of mono-/bis-thiosemicarbazones and mono-/bis-thiadiazolines substituted steroid at the C-3 position, and the best cytotoxic products were 3-thiosemicarbazones (Fig. 4, 15~17) and 3,17-bis(thiadiazolines) (18, 19) against six cancer cell lines (HeLa, K562, MDA-MB-361, MDA-MB-453, LS174 and A549), which were comparable to cisplatin. The spiro heterocyclic substituent at the C-17 position, as well as the presence of an α,β-unsaturated thiosemicarbazone moiety at C-3, enhanced the activity of the tested compounds. Fig. 4. Chemical structures of compounds 15~19 ChinaXiv合作期刊 Bufadienolides are a type of natural cardiac steroids with potent antitumor activities from the Traditional Chinese medicine Chan’Su. In order to improve their biological activity and water solubility, Hu’s group[17] designed and synthesized the bufalin 3-nitrogen-containing-ester derivatives in 2013, and found the C3 moiety of A-ring had important influence on the cytotoxic activity in SAR study. The bufalin-3-piperidinyl-4-carboxylate (Fig. 5, 21) displayed a significant cytotoxic potency compared to the parent compound bufalin with IC50 values of 0.76 and 0.34 nM against HeLa and A549 cell lines, respectively. Several years later, they found bufalin-3-yl nitrogen-containing-carbamate hydrochloride (22, IC50: 0.30 to 1.09 nM against ten tested tumor cell lines) and C4΄-substituted oleandrin analogues (23 and 24, IC50: 10.9 to 21.7 nM against human cervical carcinoma cell line) exhibited significant in vitro anti-proliferative activities[18, 19]. Fig. 5. Chemical structures of compounds 20~24 To clarify the SAR of anti-tumor activity of diosgenin derivatives in vitro, Fan’s group[20, 21] designed and synthesized 3-azole bromides substituted diosgenin derivatives (Fig. 6, 25 ~ 30) based on the three-dimensional pharmacophore docking simulation for Bcl-2 inhibitors, and SAR results indicated that chinaXiv:201711.00153v1 those with larger hydrophobic heterocyclic group have better activity through the mechanism of hydrogen bonding interaction and dipole-dipole interaction. Due to the restriction of molecular length, the side chain of compound 30 could not occupy the P2 and D3 sites compared with other derivatives, which therefore resulted in the poor antitumor activity. Fig. 6. Chemical structures of compounds 25~30 - 4 - ChinaXiv合作期刊 2016 Vol. 结 构 化 学(JIEGOU HUAXUE)Chinese J. Struct. Chem. Duan’s group firstly prepared E-salignone (Fig. 7, 31)[22] by eight steps of reactions in 16.3% total yields, and found it could inhibit the invasion of human breast cancer MDA-MB-231 cells and non-small cell lung cancer cells (A549) induced by the chemokine epidermal growth factor (EGF) with IC50 values of 0.36 and 5.77 μM, respectively. After modification, a series of antimetastatic E-salignone amide derivatives (32~34) were synthesized[23], and compound 32 was found to possess anti-migration effects in wound-healing assay. Recently, they have further prepared pregn-17(20)-en-3-amine derivatives (35~42) as anti-breast cancer [24] agents . Compared with the positive control LY294002 (IC50: 0.38 μM), the most potent anti-metastatic compound 40 exhibited 30 nM of IC50 value through the mechanism of inhibiting the phosphorylations of integrin β1, PI3K, Akt and PKCζ. Preliminary SAR indicated 3β-substituted steroid derivatives exhibited better anti-invasion activities than the 3α-substituted ones, and the α,β-unsaturated fragment in ring D might be critical for their anti-metastatic activities. Fig. 7. Chemical structures of compounds 31~42 Apart from the above acyclic chain nitrogen-containing derivatives on the A-ring of steroid skeleton, some heterocycle fused steroids were also reported as anticancer agents. Cephalostatin 1 (Fig. 8, 43)[25], a remarkably cytotoxic bis-steroidal pyrazine isolated from the marine tube worm Cephalodiscus gilchristi, has chinaXiv:201711.00153v1 become an important target for total syntheses and structural modification model for the drug discovery. Tian’s lab illustrated an efficient and practical synthesis
Recommended publications
  • 5Α-Androstane-3Α, 17Β-Diolglucuronide (3 Αdiol
    Product Data Sheet: 5α-ANDROSTANE-3α, 17β-DIOL GLUCURONIDE (3α DIOL G) ELISA ENG Catalogue number: RCD007R For research use only! Example Version BioVendor – Laboratorní medicína a.s. Karásek 1767/1, 621 00 Brno, Czech Republic +420 549 124 185 [email protected] [email protected] www.biovendor.com CONTENTS 1. INTENDED USE 3 2. PRINCIPLE OF THE TEST INTRODUCTION 3 3. CLINICAL APPLICATIONS 3 4. PROCEDURAL CAUTIONS AND WARNINGS 4 5. LIMITATIONS 5 6. SAFETY CAUTIONS AND WARNINGS 5 7. SPECIMEN COLLECTION AND STORAGE 5 8. SPECIMEN PRETREATMENT 6 9. REAGENTS AND EQUIPMENT NEEDED BUT NOT PROVIDED ASSAY PROCEDURE 6 10. REAGENTS PROVIDED 6 11. ASSAY PROCEDURE 9 12. CALCULATIONS 10 13. TYPICAL TABULATED DATA 10 14. TYPICAL CALIBRATOR CURVE 11 15. PERFORMANCE CHARACTERISTICS 11 16. EXPECTED NORMAL VALUES 14 17. REFERENCES 14 Example Version ENG.004.A 3 3 1. INTENDED USE For the direct quantitative determination of 3α Diol G by enzyme immunoassay in human serum. 2. PRINCIPLE OF THE TEST INTRODUCTION The principle of the following enzyme immunoassay test follows the typical competitive binding scenario. Competition occurs between an unlabeled antigen (present in standards, control and patient samples) and an enzyme-labelled antigen (conjugate) for a limited number of antibody binding sites on the microplate. The washing and decanting procedures remove unbound materials. After the washing step, the enzyme substrate is added. The enzymatic reaction is terminated by addition of the stopping solution. The absorbance is measured on a microtiter plate reader. The intensity of the colour formed is inversely proportional to the concentration of 3α Diol G in the sample.
    [Show full text]
  • Effects of Aminoglutethimide on A5-Androstenediol Metabolism in Postmenopausal Women with Breast Cancer1
    [CANCER RESEARCH 42, 4797-4800, November 1982] 0008-5472/82/0042-0000802.00 Effects of Aminoglutethimide on A5-Androstenediol Metabolism in Postmenopausal Women with Breast Cancer1 Charles E. Bird,2 Valerie Masters, Ernest E. Sterns, and Albert F. Clark Departments of Medicine [C. E. B., V. M.], Surgery [E. E. S.J, and Biochemistry [A. F. C.], Queen s University and Kingston General Hospital, Kingston, Ontario, Canada K7L 2V7 ABSTRACT women. More recently, we (8) and others (18) reported that the production of A5-androstene-3/8,17/8-diol in normal post- A5-Androstene-3/8,1 7/S-diol has potential estrogenic activity menopausal women is approximately 500 to 700 fig/24 hr. because it is known to bind to receptors and translocate to the AG, in combination with hydrocortisone, has been utilized to nucleus of certain estrogen target tissues. Its role in the biology inhibit estrogen production in patients with breast cancer (21 ). of breast cancer is unclear. Aminoglutethimide plus hydrocor This form of therapy has been termed "medical adrenalec tisone ("medical adrenalectomy") has been used to treat post- tomy," and studies suggest that it is as effective as surgical menopausal women with metastatic breast cancer. adrenalectomy. The hydrocortisone shuts off the basal adre- We studied A5-androstene-3/3,17/?-diol metabolism in post- nocortical production of estrogen precursors; AG not only menopausal women with breast cancer before and during slows down steroid biosynthesis at an early step but also aminoglutethimide-plus-hydrocortisone therapy, utilizing the specifically inhibits the aromatization of A4-androstenedione to constant infusion technique.
    [Show full text]
  • Perinatal Bisphenol a Exposure Increases Atherosclerosis in Adult Male PXR-Humanized Mice
    RESEARCH ARTICLE Perinatal Bisphenol A Exposure Increases Atherosclerosis in Adult Male PXR-Humanized Mice Yipeng Sui,1 Se-Hyung Park,1 Fang Wang,1 and Changcheng Zhou1 1Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky 40536 Bisphenol A (BPA) is a base chemical used extensively in numerous consumer products, and human exposure to BPA is ubiquitous. Higher BPA exposure has been associated with an increased risk of atherosclerosis and cardiovascular disease (CVD) in multiple human population-based studies. However, the underlying mechanisms responsible for the associations remain elusive. We previously reported that BPA activates the xenobiotic receptor pregnane X receptor (PXR), which has proa- therogenic effects in animal models. Because BPA is a potent agonist for human PXR but does not 2 2 affect rodent PXR activity, a suitable PXR-humanized apolipoprotein E–deficient (huPXR•ApoE / ) mouse model was developed to study BPA’s atherogenic effects. Chronic BPA exposure increased atherosclerosis in the huPXR•ApoE2/2 mice. We report that BPA exposure can also activate human PXR signaling in the heart tubes of huPXR•ApoE2/2 embryos, and perinatal BPA exposure exac- erbated atherosclerosis in adult male huPXR•ApoE2/2 offspring. However, atherosclerosis devel- opment in female offspring was not affected by perinatal BPA exposure. Perinatal BPA exposure did not affect plasma lipid levels but increased aortic and atherosclerotic lesional fatty acid transporter 2 2 CD36 expression in male huPXR•ApoE / offspring. Mechanistically, PXR epigenetically regulated CD36 expression by increasing H3K4me3 levels and decreasing H3K27me3 levels in the CD36 promoter in response to perinatal BPA exposure. The findings from the present study contribute to our understanding of the association between BPA exposure and increased atherosclerosis or CVD risk in humans, and activation of human PXR should be considered for future BPA risk assessment.
    [Show full text]
  • Androstane-3\G=A\,17\G=B\-Dioland 5\G=A\-Androstane\X=Req-\ 3\G=B\,17\G=B\-Diolby Rat Testicular Cells in Vitro R
    Age-related changes in conversion of 5\g=a\-androstan-17\g=b\-ol\x=req-\ 3-one to 5\g=a\-androstane-3\g=a\,17\g=b\-dioland 5\g=a\-androstane\x=req-\ 3\g=b\,17\g=b\-diolby rat testicular cells in vitro R. C. Cochran, A. W. Schuetz and L. L. Ewing Division ofReproductive Biology, Department ofPopulation Dynamics, The Johns Hopkins University, School ofHygiene and Public Health, Baltimore, Maryland 21205, U.SA. Summary. Conversion of labelled 5\g=a\-androstan-17\g=b\-ol-3-one(DHT) by isolated testicular cells from rats of different ages was examined under saturating substrate conditions in vitro (5\p=n-\10\g=m\gDHT/ml in a 24 h incubation). Two detectable metabolites of DHT were produced by testicular cells in vitro, 5\g=a\-androstane\x=req-\ 3\g=a\-17\g=b\-diol(3\g=a\-diol)and 5\g=a\-androstane-3\g=b\,17\g=b\-diol(3\g=b\-diol).Production of these diols during a 24 h period was linear, and the amounts formed were directly related to the cell number. The amount of 3\g=a\-and 3\g=b\-diolsformed by testicular cells of rats of different ages increased from Day 10 to Day 25, then declined. Testicular cells from rats 10 to 20 days of age converted DHT mainly to 3\g=a\-diol,but thereafter 3\g=b\\x=req-\ diol was the predominant testicular metabolite of DHT. Introduction Testosterone is the major metabolite of progesterone in testicular tissue sUce preparations taken from rats aged 0-17 days (Ficher & Steinberger, 1968).
    [Show full text]
  • New Mechanisms and Chemicals
    Copyedited by: OUP MINI REVIEW Environmental Obesogens and Their Impact on Susceptibility to Obesity: New Mechanisms and Chemicals Riann Jenay Egusquiza1,2 and Bruce Blumberg1,2,3 Downloaded from https://academic.oup.com/endo/article-abstract/161/3/bqaa024/5739626 by guest on 01 May 2020 1Department of Developmental and Cell Biology, University of California Irvine, Irvine, California 92697- 2300; 2Department of Pharmaceutical Sciences, University of California Irvine, Irvine, California 92697; and 3Department of Biomedical Engineering, University of California Irvine, Irvine, California 92697 ORCiD numbers: 0000-0002-6731-1087 (R. J. Egusquiza); 0000-0002-8016-8414 (B. Blumberg). The incidence of obesity has reached an all-time high, and this increase is observed worldwide. There is a growing need to understand all the factors that contribute to obesity to effectively treat and prevent it and associated comorbidities. The obesogen hypothesis proposes that there are chemicals in our environment termed obesogens that can affect individual susceptibility to obesity and thus help explain the recent large increases in obesity. This review discusses current advances in our understanding of how obesogens act to affect health and obesity susceptibility. Newly discovered obesogens and potential obesogens are discussed, together with future directions for research that may help to reduce the impact of these pervasive chemicals. (Endocrinology 161: 1–14, 2020) Key Words: obesity, obesogen, endocrine disrupting chemicals, EDCs, transgenerational, adipogenesis besity is a pandemic that has reached worldwide diseases, and cancers, and have contributed to approxi- O proportions, affecting essentially every country mately 4 million deaths worldwide between 1980 and (1). The most dramatic increase in obesity incidence has 2015 (3).
    [Show full text]
  • Identification and Validation of Novel Hpxr Activators Amongst
    DMD Fast Forward. Published on November 10, 2010 as DOI: 10.1124/dmd.110.035808 DMD FastThis Forward. article has not Published been copyedited on andNovember formatted. The 10, final 2010 version as maydoi:10.1124/dmd.110.035808 differ from this version. DMD #35808 Identification and Validation of Novel hPXR Activators Amongst Prescribed Drugs via Ligand-Based Virtual Screening Yongmei Pan, Linhao Li, Gregory Kim, Sean Ekins, Hongbing Wang and Peter W. Swaan Downloaded from Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 Penn Street, Baltimore, MD 21201, USA; Collaborations in Chemistry, Jenkintown, PA 19046, USA (SE); Department of Pharmacology, University of Medicine & Dentistry dmd.aspetjournals.org of New Jersey (UMDNJ)-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA (SE). at ASPET Journals on September 24, 2021 1 Copyright 2010 by the American Society for Pharmacology and Experimental Therapeutics. DMD Fast Forward. Published on November 10, 2010 as DOI: 10.1124/dmd.110.035808 This article has not been copyedited and formatted. The final version may differ from this version. DMD #35808 a) Running Title: Identification of Novel hPXR Activators b) Corresponding Author: Peter W. Swaan, Ph.D., Department of Pharmaceutical Sciences, University of Maryland, 20 Penn Street, HSF2-621, Baltimore, MD 21201 USA Tel: (410) 706-0103 Fax: (410) 706-5017 Email: [email protected] Downloaded from c) Number of: Text pages: 35 dmd.aspetjournals.org Tables: 3 Figures: 6 References: 45 at ASPET Journals on September 24, 2021 Words in Abstract: 196 Words in Introduction: 546 Words in Discussion: 1,521 d) Abbreviations: hPXR, Human pregnane X receptor; LBD, ligand binding domain; XV ROC AUC, Leave-one-out cross-validation based ‘receiver operator curve’ area under the curve.
    [Show full text]
  • CYP7B1-Mediated Metabolism of Dehydroepiandrosterone and 5A
    CYP7B1-mediated metabolism of dehydroepiandrosterone and 5a-androstane-3b,17b-diol – potential role(s) for estrogen signaling Hanna Pettersson1, Lisa Holmberg1, Magnus Axelson2 and Maria Norlin1 1 Department of Pharmaceutical Biosciences, Division of Biochemistry, University of Uppsala, Sweden 2 Department of Clinical Chemistry, Karolinska Hospital, Stockholm, Sweden Keywords CYP7B1, a cytochrome P450 enzyme, metabolizes several steroids involved cytochrome P450; estrogen receptor; in hormonal signaling including 5a-androstane-3b,17b-diol (3b-Adiol), an hydroxylase; sex hormone; steroid estrogen receptor agonist, and dehydroepiandrosterone, a precursor for sex metabolism hormones. Previous studies have suggested that CYP7B1-dependent metab- Correspondence olism involving dehydroepiandrosterone or 3b-Adiol may play an impor- M. Norlin, Department of Pharmaceutical tant role for estrogen receptor b-mediated signaling. However, conflicting Biosciences, Division of Biochemistry, data are reported regarding the influence of different CYP7B1-related University of Uppsala, Box 578, steroids on estrogen receptor b activation. In the present study, we investi- S-751 23 Uppsala, Sweden gated CYP7B1-mediated conversions of dehydroepiandrosterone and Fax: +46 18 558 778 3b-Adiol in porcine microsomes and human kidney cells. As part of these Tel: +46 18 471 4331 studies, we compared the effects of 3b-Adiol (a CYP7B1 substrate) and E-mail: [email protected] 7a-hydroxy-dehydroepiandrosterone (a CYP7B1 product) on estrogen (Received 19 December 2007, revised 13 receptor b activation. The data obtained indicated that 3b-Adiol is a more February 2008, accepted 14 February 2008) efficient activator, thus lending support to the notion that CYP7B1 cataly- sis may decrease estrogen receptor b activation. Our data on metabolism doi:10.1111/j.1742-4658.2008.06336.x indicate that the efficiencies of CYP7B1-mediated hydroxylations of dehy- droepiandrosterone and 3b-Adiol are very similar.
    [Show full text]
  • Binding Characteristics of a Major Protein in Rat Ventral Prostate Cytosol That Interacts with Estramustine, a Nitrogen Mustard Derivative of 17ß-Estradiol
    [CANCER RESEARCH 39, 5155-5164, December 1979] 0008-5472/79/0039-OOOOS02.00 Binding Characteristics of a Major Protein in Rat Ventral Prostate Cytosol That Interacts with Estramustine, a Nitrogen Mustard Derivative of 17ß-Estradiol BjörnForsgren, Jan-Àke Gustafsson, Ake Pousette, and Bertil Hogberg AB Leo Research Laboratories. Pack. S-251 00 Helsingborg, Sweden [B.F.. B.H.], and Departments of Chemistry and Medical Nutrition. ¡J-ÄG.. A P.¡and Pharmacology [BH.], Karolinska Institute!. S-104 01 Stockholm 60. Sweden ABSTRACT causes atrophy of the testes and accessory sex organs; re duces the uptake of zinc by the prostate; depresses the 5a- The tissue distribution of [3H]estramustine, the dephospho- reductase, arginase, and acid phosphatase activities in the rylated metabolite of estramustine phosphate (Estracyt), in the male rat was compared to that of [3H]estradiol 30 min and 2 hr prostate; and affects lipid and carbohydrate metabolism (10, 11, 20, 29, 31 -33, 42). Although the observed effects in many following i.p. administration. In contrast to estradiol, estramus respects are similar to estrogenic effects, several experimental tine was found to be efficiently concentrated in the ventral and clinical results indicate that estramustine phosphate affects prostate gland by a soluble protein. The binding characteristics normal and neoplastic prostate tissue in a way that cannot be of this protein were studied in vitro using cytosol preparations attributed solely to its antigonadotropic or weak estrogenic of the gland. With a dextran-coated charcoal technique, the properties (15, 16, 30, 38). protein was found to bind estramustine with a broad pH opti Plym Forshell and Nilsson (35), using labeled compounds (1 mum between pH 7 and pH 8.5, with an apparent Kd of 10 to to 10 mg/kg body weight), found considerably higher levels of 30 nw, and with a binding capacity of about 5 nmol/mg cytosol radioactivity in the rat ventral prostate following i.v.
    [Show full text]
  • Documentation, Codebook, and Frequencies
    Documentation, Codebook, and Frequencies Surplus Sera Laboratory Component: Racial/Ethnic Variation In Sex Steroid Hormone Concentrations Across Age In US Men Survey Years: 1988 to 1991 SAS Export File: SSHORMON.XPT First Published: October 2006 Last revised: N/A NHANES III Data Documentation Laboratory Assessment: Racial/Ethnic Variation in Sex Steroid Hormone Concentrations Across Age In US Men (NHANES III Surplus Sera) Years of Coverage: 1988-1991 First Published: October 2006 Last Revised: N/A Introduction It has been proposed that racial/ethnic variation in prostate cancer incidence may be, in part, due to racial/ethnic variation in sex steroid hormone levels. However, it remains unclear whether in the US population circulating concentrations of sex steroid hormones vary by race/ethnicity. To address this, concentrations of testosterone, sex hormone binding globulin, androstanediol glucuronide (a metabolite of dihydrotestosterone) and estradiol were measured in stored serum specimens from men examined in the morning sample of the first phase of NHANES III (1988-1991). This data file contains results of the testing of 1637 males age 12 or more years who participated in the morning examination of phase 1 of NHANES III and for whom serum was still available in the repository. Data Documentation for each of these four components is given in sections below. I. Testosterone Component Summary Description The androgen testosterone (17β -hydroxyandrostenone) has a molecular weight of 288 daltons. In men, testosterone is synthesized almost exclusively by the Leydig cells of the testes. The secretion of testosterone is regulated by luteinizing hormone (LH), and is subject to negative feedback via the pituitary and hypothalamus.
    [Show full text]
  • Serum Levels of 3A-Androstanediol Glucuronide in Hirsute and Non Hirsute Women
    European Journal of Endocrinology (1998) 138 421–424 ISSN 0804-4643 Serum levels of 3a-androstanediol glucuronide in hirsute and non hirsute women L Falsetti, B Rosina and D De Fusco Department of Gynaecological Endocrinology, University of Brescia, Italy (Correspondence should be addressed to L Falsetti, Via Tirandi, 13-scala F, 25128 Brescia, Italy) Abstract This study has evaluated the behaviour of 3a-androstanediol glucuronide (3a-diol G) in 170 women of whom 85 had polycystic ovary syndrome (PCOS), 35 had idiopathic hirsutism (IH) and 50 had regular cycles (control group). Of the women with PCOS, 45 were hirsute (PCOS-H) and 40 were non hirsute (PCOS-NH). Women in the control group were not hirsute. Hirsutism was assessed by the same physician using the Ferriman-Gallway score. The body mass index (BMI) was estimated in all of the women. Plasma concentrations of 3a-diol G were elevated only in hirsute patients, both with PCOS and with IH. Even in PCOS-NH, concentrations of 3a-diol G were higher compared with controls (P<0.001), but significantly lower (P < 0.001) than those of the PCOS-H and of the IH groups. The behaviour of 3a- diol G was not affected by BMI. European Journal of Endocrinology 138 421–424 Introduction The aim of our study is to provide further contri- butions to the clinical activity of 3a-diol G by evaluat- Hirsutism, affecting 5–8% of the whole female popula- ing its behaviour in a broad series of normal and tion of fertile age, is an important clinical and hyperandrogenic women, with and without hirsutism.
    [Show full text]
  • New Estrone Oxime Derivatives: Synthesis, Cytotoxic Evaluation and Docking Studies
    molecules Article New Estrone Oxime Derivatives: Synthesis, Cytotoxic Evaluation and Docking Studies Catarina Canário 1 , Mariana Matias 1, Vanessa Brito 1, Adriana O. Santos 1, Amílcar Falcão 2,3 , Samuel Silvestre 1,4,* and Gilberto Alves 1 1 CICS-UBI–Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal; [email protected] (C.C.); [email protected] (M.M.); [email protected] (V.B.); [email protected] (A.O.S.); [email protected] (G.A.) 2 Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal; [email protected] 3 CIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal 4 CNC–Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal * Correspondence: [email protected] Abstract: The interest in the introduction of the oxime group in molecules aiming to improve their biological effects is increasing. This work aimed to develop new steroidal oximes of the estrane series with potential antitumor interest. For this, several oximes were synthesized by reaction of hydroxylamine with the 17-ketone of estrone derivatives. Then, their cytotoxicity was evaluated in six cell lines. An estrogenicity assay, a cell cycle distribution analysis and a fluorescence microscopy study with Hoechst 3358 staining were performed with the most promising compound. In addition, molecular docking studies against estrogen receptor α, steroid sulfatase, 17β-hydroxysteroid dehy- drogenase type 1 and β-tubulin were also accomplished. The 2-nitroestrone oxime showed higher Citation: Canário, C.; Matias, M.; Brito, V.; Santos, A.O.; Falcão, A.; cytotoxicity than the parent compound on MCF-7 cancer cells.
    [Show full text]
  • Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum
    Neuropsychopharmacology (2018) 43, 1436–1444 © 2018 American College of Neuropsychopharmacology. All rights reserved 0893-133X/18 www.neuropsychopharmacology.org Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum ,1 1 1 2 2 Laura E Dichtel* , Elizabeth A Lawson , Melanie Schorr , Erinne Meenaghan , Margaret Lederfine Paskal , 3 4 4 5,6 1 Kamryn T Eddy , Graziano Pinna , Marianela Nelson , Ann M Rasmusson , Anne Klibanski and 1 Karen K Miller 1 2 Neuroendocrine Unit, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA; Neuroendocrine Unit, Massachusetts General 3 Hospital, Boston, MA, USA; Eating Disorders Clinical and Research Program, Massachusetts General Hospital/Harvard Medical School, Boston, 4 5 MA, USA; The Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA; National Center for PTSD, Department of Veterans Affairs, VA Boston Healthcare System, Boston, MA, USA; 6Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA α α α α β 3 -5 -Tetrahydroprogesterone, a progesterone metabolite also known as allopregnanolone, and 5 -androstane-3 ,17 -diol, a α testosterone metabolite also known as 3 -androstanediol, are neuroactive steroids and positive GABAA receptor allosteric modulators. Both anorexia nervosa (AN) and obesity are complicated by affective comorbidities and hypothalamic–pituitary–gonadal dysregulation. However, it is not known whether neuroactive steroid levels are abnormal at the extremes of the weight spectrum. We hypothesized that serum allopregnanolone and 3α-androstanediol levels would be decreased in AN compared with healthy controls (HC) and negatively associated with affective symptoms throughout the weight spectrum, independent of body mass index (BMI). Thirty-six women were 1 : 1 age-matched across three groups: AN, HC, and overweight/obese (OW/OB).
    [Show full text]